3.30.50.10.FF4220, a nuclear receptor family particularly likely to be free of side effects, contains proteins such as RXRA, RXRB and RXRG which show high expression in bladder cancer and are currently drug targets in other cancers (breast and prostate). This evidence concerns the gene RXRG and urinary bladder cancer.